Rezolute (RZLT) Other Accumulated Expenses (2014 - 2023)
Rezolute (RZLT) reported Other Accumulated Expenses of $1.1 million for Q1 2023, up 46.73% on a YoY basis from $764000.0 in Q1 2022, and up 4.67% sequentially from $1.1 million in Q4 2022.
Rezolute (RZLT) Other Accumulated Expenses (2014 - 2023) Analysis & Trends
Rezolute (RZLT) has 10 years of Other Accumulated Expenses data on file, last reported at $1.1 million in Q1 2023.
- For the quarter ending Q1 2023, Other Accumulated Expenses rose 46.73% year-over-year to $1.1 million; the trailing twelve-month figure through Mar 2023 stood at $1.1 million (up 46.73% YoY), and the FY2022 full-year result was $243000.0, changed 0.41% from the prior year.
- Other Accumulated Expenses rose to $1.1 million in Q1 2023, from $1.1 million in the prior quarter.
- In the past five years, Other Accumulated Expenses ranged from a high of $1.1 million in Q1 2023 to a low of $122000.0 in Q3 2022.
- A 5-year average of $486357.1 and a median of $388500.0 in 2020 frame the typical range for Other Accumulated Expenses.
- Across the five-year window, Other Accumulated Expenses jumped 361.4% in 2019 and tumbled 82.03% in 2022, its largest moves.
- Tracing RZLT's Other Accumulated Expenses over 5 years: stood at $641000.0 in 2019, then sank by 53.2% to $300000.0 in 2020, then surged by 59.0% to $477000.0 in 2021, then jumped by 124.53% to $1.1 million in 2022, then gained by 4.67% to $1.1 million in 2023.
- Business Quant data shows RZLT's Other Accumulated Expenses at $1.1 million in Q1 2023, $1.1 million in Q4 2022, and $122000.0 in Q3 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,042.03 Bn | 67,041.74 Bn | - |
| 2 | Nanobiotix | 1,908.00 Bn | 1,907.94 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 472.89 Bn | 468.10 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.12 Bn | 114.87 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.04 Bn | 61.29 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.68 Bn | 62.68 Bn | - |
| 8 | Argenx Se | 55.90 Bn | 50.72 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.47 Bn | 34.46 Bn | 959.66 Mn |
| 10 | Rezolute | 515.52 Mn | 515.52 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 1.12 Mn |
| Dec 31, 2022 | 1.07 Mn |
| Sep 30, 2022 | 122,000.00 |
| Jun 30, 2022 | 243,000.00 |
| Mar 31, 2022 | 764,000.00 |
| Dec 31, 2021 | 477,000.00 |
| Sep 30, 2021 | 679,000.00 |
| Jun 30, 2021 | 242,000.00 |
| Sep 30, 2020 | 300,000.00 |
| Jun 30, 2020 | 180,000.00 |
| Mar 31, 2020 | 284,000.00 |
| Dec 31, 2019 | 641,000.00 |
| Sep 30, 2019 | 159,000.00 |
| Jun 30, 2019 | 526,000.00 |
| Sep 30, 2018 | 132,922.00 |
| Jun 30, 2018 | 114,000.00 |
| Mar 31, 2018 | 121,705.00 |
| Dec 31, 2017 | 116,234.00 |
| Sep 30, 2017 | 110,765.00 |
| Jun 30, 2017 | 105,295.00 |